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2,5-Dihydrophenylalanine (H2Phe) is a multipotent
nonproteinogenic amino acid produced by various
Actinobacteria and Gammaproteobacteria. Although
the metabolite was discovered over 40 years ago,
details of its biosynthesis have remained largely
unknown. We show here that L-H2Phe is a secreted
metabolite in Photorhabdus luminescens cultures
and a precursor of a recently described 2,5-dihy-
drostilbene. Bioinformatic analysis suggested a
candidate gene cluster for the processing of pre-
phenate to H2Phe, and gene knockouts validated
that three adjacent genes plu3042–3044 were
required for H2Phe production. Biochemical experi-
ments validated Plu3043 as a nonaromatizing pre-
phenate decarboxylase generating an endocyclic di-
hydro-hydroxyphenylpyruvate. Plu3042 acted next
to transaminate the Plu3043 product, precluding
spontaneous exocyclic double-bond isomerization
and yielding 2,5-dihydrotyrosine. The enzymatic
products most plausibly on path to H2Phe illustrate
the versatile metabolic rerouting of prephenate
from aromatic amino acid synthesis to antibiotic
synthesis.
INTRODUCTION
2,5-Dihydrophenylalanine (H2Phe, (S)-2-amino-3-(cyclohexa-
1,4-dienyl) propanoic acid, Figure 1A) has long been known
as an antimetabolite of Phe (Nass et al., 1971). Initially, H2Phe
was detected as an unintendedby-product of theBirch reduction
of antibiotics evolidine and bacitracin (Ressler and Kashelikar,
1966), though its synthesis was later intentionally optimized and
its biological activity was investigated (Snow et al., 1968). The
compoundwas subsequently identified as a natural product pro-
duced by several Streptomyces species (Scannell et al., 1970;
Yamashita et al., 1970; Fickenscher et al., 1971), Pseudomonas
sp. Strain I-30 (Onishi et al., 1982), and Erwinia amylovora (Feist-
ner, 1988).
H2Phe possesses a myriad of biological activities, most
presumably arising from its ability to act as an antagonist of1102 Chemistry & Biology 18, 1102–1112, September 23, 2011 ª201Phe. It has broad-spectrum antimicrobial activity (Genghof,
1970) and will inhibit E. coli growth unless external sources of
Phe are provided in culture media (Fickenscher and Za¨hner,
1971). It is believed that this antibiotic action arises from
false-feedback inhibition of the shikimate pathway because
the planar structure (Shoulders et al., 1968) of H2Phe allows
it to serve as a Phe analog (Genghof, 1970). In fact, H2Phe
can be incorporated into proteins during translation in place
of Phe (Pine, 1975). H2Phe can also function as an antifungal
via disruption of microtubule assembly (Kiso et al., 2004).
Studies with mammalian cell lines have shown that in human
promyelocytic leukemia cells H2Phe induces cathepsin-
dependent apoptosis (Kiso et al., 2001). In vivo studies on
young rats show that addition of this compound to their
diet induced anorexia and was cytotoxic (Snow et al., 1968).
Plants are also negatively impacted by H2Phe. The plant
pathogen E. amylovora, which causes a devastating disease
to apple and pear trees called Fire blight, produces H2Phe
as a virulence factor (Schwartz et al., 1991). This compound
has been shown to decrease production of phytoalexins,
indicating that the compound acted to decrease the plant’s
defensive responses to pathogens (Feistner, 1988; Schwartz
et al., 1991).
Biosynthetic investigations into H2Phe production have
focused primarily on determination of the metabolic precursor
to the compound. It has been shown that H2Phe is not derived
from reduction of Phe (Scannell et al., 1970) but is in fact
produced from prephenate, an upstream primary metabolic
precursor to Phe (Shimada et al., 1978). Furthermore, isotopic-
labeling studies indicate that the enzymes that convert prephen-
ate to H2Phe are capable of distinguishing between the two
enantiotopically related halves of the prephenate cyclohexa-
dienyl ring (Figure 1A) (Shimada et al., 1978). Given that the
conversion of prephenate to H2Phe must at some point involve
a reduction, the possibility that a reduced prephenate derivative
(dihydroprephenate) would be used in the biosynthetic pathway
was raised. However, feeding of the tritium-labeled dihydropre-
phenic acid to a H2Phe-producing Streptomyces strain did not
result in formation of radiolabeled H2Phe, indicating that reduc-
tion proceeds not on the prephenate scaffold but on a down-
stream intermediate (Shimada et al., 1978).
Our recent work has established a new family of prephenate-
utilizing enzymes that reroutes prephenate away from aromatic
amino acid biosynthesis into secondary metabolism (Mahlstedt
and Walsh, 2010; Mahlstedt et al., 2010). These prephenate1 Elsevier Ltd All rights reserved
Figure 1. Prephenate-Derived Nonproteinogenic Amino Acids
(A) Prephenate is the metabolic precursor to H2Phe. The biochemical trans-
formations required to produce H2Phe distinguish between the two halves of
the starting material in production of the final amino acid product.
(B) PDX enzymes decarboxylate prephenate to produce H2HPPen, which
can nonenzymatically undergo isomerization to H2HPPex. PDX catalyzed
decarboxylative isomerization can yield the S or R configuration at the C7
position of H2HPPen. Based on the isotopic-labeling studies in (A) and
the double-bond positions in H2HPPen, C7 is assumed to adopt the R
configuration in H2Phe biosynthesis.
(C) Selected examples of prephenate-derived nonproteinogenic amino acid
products.
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aromatize prephenate to produce an endocyclic dihydro-
hydroxyphenylpyruvate (‘‘H2HPPen,’’ 3-(4-hydroxycyclohexa-
1,5-dienyl)-2-oxopropanoic acid) (Figure 1B). This scaffold
can then be transformed to a range of biologically relevant
nonproteinogenic amino acids, such as tetrahydrotyrosine
(H4Tyr), tetrahydrophenylalanine (H4Phe), choi, and anticapsin
(Figure 1C) (Mahlstedt and Walsh, 2010; Mahlstedt et al.,
2010). Given the similarity of H2Phe to these amino acids
and the knowledge that it is derived from prephenate, we sus-
pected the involvement of this novel enzyme family. In this work,
we identify L-H2Phe as a secreted product of the insect-
pathogenic bacterium, Photorhabdus luminescens, determine
its intermediacy in the biosynthesis of the recently discovered
2,5-dihydrostilbene product (Kontnik et al., 2010), identify a
gene cluster involved inH2Phe biosynthesis, and begin a detailed
in vitro biochemical investigation into the formation of this
multipotent nonproteinogenic amino acid.Chemistry & Biology 18, 1102–111RESULTS
Identification of Candidate Gene Cluster
Putative PDXs were identified in the genomes of E. amylovora
and P. luminescens encoded by eamy2205 and plu3043, re-
spectively. Intriguingly, inspection of the sequence surrounding
these genes revealed the existence of an eight-gene set
conserved in both organisms (Figure 2; see Table S1 available
online). Based on the finding that this gene cluster encoded
proteins that could be biosynthetic (eamy2203 and plu3041,
phenylacetate-CoA ligase; eamy2204 and plu3042, PLP-depen-
dent aminotransferase; eamy2206 and plu3044, AhpD-family
disulfide peroxidase; eamy2207 and plu3045, ornithine cyclo-
deaminase), we suspected that this could be a natural product
gene cluster. Additionally, a clustered amino acid efflux protein
homolog (eamy2208 and plu3046, transporter) would presum-
ably provide the host with resistance to the encoded product
by transporting the small molecule into the culture medium.
A literature search revealed the existence of a prephenate-
derived H2Phe product produced by E. amylovora (Feistner,
1988). Although H2Phe had not been identified as a product of
P. luminescens, the recent discovery of a 2,5-dihydrostilbene
product from the microorganism suggested that it could be
produced as an intermediate in the construction of reduced
stilbenes (Kontnik et al., 2010). With this knowledge we
chose to determine whether H2Phe could be isolated from
P. luminescens, to examine this cluster’s relevance in H2Phe
biosynthesis by constructing genetic knockouts, and to initiate
in vitro biochemical characterization of the pathway.
Identification of L-H2Phe in Wild-Type P. luminescens
and Knockout Strains
To determine the presumed gene cluster’s role in the biosyn-
thesis of H2Phe, scar-less deletions of plu3042, plu3043,
plu3044, and plu3045 were individually constructed in
P. luminescens TT01 utilizing allelic exchange mutagenesis
(Figure 3A). The resulting strains were cultivated in an L-proline
rich medium to enhance production of secondary metabolites
(Crawford et al., 2010). Using liquid chromatography-mass
spectrometry (LC/MS), differential analysis of the secreted
metabolites between wild-type cultures and mutant cultures
was conducted to identify deleted products. Comparisons of
ultraviolet and visible (UV/Vis) absorption traces showedminimal
differences among the strains due to the complex metabolic
backgrounds. However, comparisons of the MS profiles showed
a dramatic difference in the production of a positive ion at
168 atomic mass units, consistent with protonated H2Phe
(Figure 3B). The gene products Plu3042, Plu3043, and Plu3044
were required for its synthesis because deletion of plu3042,
plu3043, and plu3044 completely abrogated production. The
Dplu3045 strain continued production at levels comparable to
wild-type under the conditions of the experiment.
We developed a method for the extraction and purification
of the identified 168 positive ion from the lyophilized cleared
culture medium. Due to the low ultraviolet absorption of the
secreted product, it was tracked by LC/MS through each
purification step. The purified product was subjected to detailed
1D- (1H) and 2D-NMR analyses (gCOSY, HSQCAD, and gHMBC)
(Table 1; Figures S1A–S1E) and high-resolution MS (C9H14NO2;2, September 23, 2011 ª2011 Elsevier Ltd All rights reserved 1103
Figure 2. Gene Cluster in P. luminescens and E. amylovora Shown to Be Involved in H2Phe Biosynthesis
See also Table S1 and Figure S3.
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Dihydrophenylalanine Biosynthesiscalculated 168.1025; observed, 168.1026; error 0.6 ppm). All
data are in agreement with the conclusion that the identified
ion produced by P. luminescens TT01 represents H2Phe.
H2Phe slowly undergoes spontaneous oxidative aromatization
to Phe in the presence of air (Snow et al., 1968), and rotary evap-
oration causes aromatization (Feistner, 1988). To identify the
absolute configuration of the P. luminescens product, isolated
H2Phe was subjected to several rounds of rotary evaporation
from water, and the oxidation product was analyzed using the
Marfey’s method (Marfey, 1984; Fujii et al., 1997). The Marfey’s
derivatized product coeluted with L-Phe, but not D-Phe, indi-
cating that the secreted metabolite is L-H2Phe (Figure S1F).
L-H2Phe Is an Intermediate in 2,5-Dihydrostilbene
Biosynthesis
P. luminescens is involved in a multipartite symbiosis, in
which the bacterium has formed an evolutionary alliance with
Heterorhabditis nematodes to effectively kill a wide range of
insect larvae in the soil (Waterfield et al., 2009). The bacterium
also produces a broad range of antibiotics, in addition to
H2Phe identified here, to overcome the insect host and outcom-
pete competitors in the decomposing insect carcass. During the
P. luminescens lifecycle, the bacterium oscillates between its
mutualistic nematode host and its pathogenic insect host. A
LysR-type transcriptional repressor, HexA, was implicated in
regulating the mutualist-pathogen transition in the related
bacterium, Photorhabdus temperata (Joyce and Clarke, 2003).
Bacteria belonging to the Photorhabdus genera are the only
described bacterial producers of stilbenes (Richardson et al.,
1988), which are common phenylpropanoid plant products
(Chong et al., 2009), and deletion of the HexA regulator in
P. luminescens and P. temperata led to an upregulation of the
stilbene class (Kontnik et al., 2010). Interestingly, 2,5-dihydrostil-
bene ((E)-5-(2-(cyclohexa-1,4-dienyl)vinyl)-2-isopropylbenzene-1104 Chemistry & Biology 18, 1102–1112, September 23, 2011 ª2011,3-diol, Figures 4A and 4B) is dramatically upregulated in the
P. luminescens hexA mutant, which is barely detectable in
wild-type cultures grown in rich lab media (Kontnik et al., 2010).
To determine if the secreted L-H2Phe antibiotic also serves
as an intermediate in 2,5-dihydrostilbene biosynthesis, a 13C6-
labeled H2Phe derivative was synthesized via a Birch reduction
of 13C6-labeled L-Phe for isotopic-labeling studies (Figure 4A)
(Skolaut and Re´tey, 2001). Various concentrations of the
synthetic 13C6-L-H2Phe were fed to the P. luminescens hexA
mutant. As judged by LC/MS analysis of organic extracts,
increasing concentrations of exogenous 13C6-L-H2Phe in the
culture medium led to an increase in 2,5-dihydrostilbene pro-
duction (Figures 4B and 4C) with a concomitant increase in
13C6-isotopic enrichment (Figure 4D; Figure S2A). The isotopic-
labeling studies indicate that whereas L-H2Phe is a secreted
metabolite, it can also serve as an intermediate in 2,5-dihydros-
tilbene biosynthesis. 13C6-L-H2Phe also incorporated to an
extent into the major aromatic stilbene (Figure 4B, negative
ion, m/z (12C6) = 253 and m/z (
13C6) = 259), although oxidation
of labeled H2Phe, 2,5-dihydrostilbene, or any intermediate
between could contribute to the isotopic enrichment.
Given that the biosynthesis of phenylpropanoids, such as the
stilbenes, is initiated by a Phe ammonia lyase that converts Phe
to cinnamate (Vogt, 2010), one would expect the corresponding
reduced 2,5-dihydrocinnamate ((E)-3-(cyclohexa-1,4-dienyl)
acrylic acid) to also be involved in 2,5-dihydrostilbene biosyn-
thesis. As in our H2Phe LC/MSanalysis above (Figure 3), a positive
ion peak (m/z = 151) consistent with protonated 2,5-
dihydrocinnamic acid was also detected as a secreted product in
the cleared culture medium only in wild-type and in the plu3045
mutant strain cultures (Figure S2B). Lowproductionof the interme-
diate precluded detailed structural characterization. Complete
abrogation of the ion product in the three mutants, plu3042–
plu3044, provides genetic support for the production of1 Elsevier Ltd All rights reserved
Figure 3. Genetic Connection of Candidate Biosynthetic Gene Cluster to H2Phe
(A) Scar-less deletion mutants constructed in P. luminescens using allelic-exchange mutagenesis.
(B) Genes plu3042, plu3043, and plu3044were required for the synthesis of H2Phe. Deletion of plu3045 showed no effect. The LC/MS ion current window (167.7–
168.7) for protonated H2Phe (m/z = 168 ion) is shown for wild-type and each of the mutants.
See also Table S3.
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drostilbene biosynthesis. Aromatization of the cyclohexadienyl
side chain of the secretedH2Phe, 2,5-dihydrocinnamate, or 2,5-di-
hydrostilbene would likely occur when subjected to the insect’s
oxidative defenses (Kontnik et al., 2010). Strikingly, the aromatic
stilbene derivative has been shown to serve as an antimicrobial
(Hu andWebster, 2000), insect immunosuppressant (Eleftherianos
etal., 2007),andnematodedevelopment signal (Joyceetal., 2008).
Expression of Plu3042, Plu3043, and Plu3044 in E. coli
and Protein Purification
To begin investigating the biochemical transformations from
prephenate to L-H2Phe, the biosynthetically required genesChemistry & Biology 18, 1102–111plu3042, plu3043, and plu3044 were amplified by PCR from
P. luminescens TT01 genomic DNA. The PCR products were
cloned into a pET-28b expression vector that was then trans-
formed into the E. coli BL21(DE3) expression strain. The ex-
pressedproteins eachharbor aN-terminalHis6 tag, allowingpuri-
fication of the protein by Ni-NTA affinity chromatography to near
homogeneity (SDS-PAGE analysis, Figure S3A). Plu3042 was
acquired at 19.5 mg/l yield, Plu3043 at 19.5 mg/l, and Plu3044
at 25 mg/l. A minor truncation product of Plu3042
was observed by SDS-PAGE analysis. Both the major and
minor protein products were identified to be Plu3042 by pro-
teolytic digestion (trypsin) and LC/MALDI-MS/TOF-TOF analysis
(Figure S3B).2, September 23, 2011 ª2011 Elsevier Ltd All rights reserved 1105
Table 1. 1H and 13C Data for L-H2Phe in D2O
13C ppm 1H ppm, mult. (Hz) gCOSY gHMBC
1 177.6
2 52.9 3.68, dd (4.7, 9.3) 3a/3b 1, 3, 4
3a 39.8 2.37, dd (14.5, 9.2) 2, 3b, 9 w 1, 2, 4, 5, 9
3b 2.56, dd (14.3, 4.5) 2, 3a, 9 w 1, 2, 4, 5, 9
4 129.8
5 27.6 2.6–2.75 (2.63 m)a 6 4, 8, 6/7/9 o
6 124.61 5.79 m 5 4, 5, 8, 7/9 o
7 124.61 5.79 m 8 5, 8, 6/9 o
8 26.3 2.7–2.75 (2.73 m)a 7, 9 4, 5, 6/7/9 o
9 124.58 5.66 br s 3a/3b w, 8 3, 5/8 w, 6/7 o
The 1H signal was referenced to solvent, and the 13C signal was refer-
enced by VNMRJ software (Varian). br, broad; w, weak; o, overlapped;
mult, multiplicity.
a Signals in multiplet were distinguishable in gCOSY and HSQCAD exper-
iments. The 1H and 13C chemical shift values of the isolated metabolite
were similar to the previously reported synthetic H2Phe trifluoroacetic
acid salt (Skolaut and Re´tey, 2001), except the pH-sensitive C1 carbon
and the a- and b-proton signals were slightly shifted. See also Figure S1.
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Plu3043 is a predicted homolog to the BacA, SalX, and AerD
enzymes, which were previously shown to convert prephenate
to the nonaromatized H2HPPen (Figure 1B) (Mahlstedt and
Walsh, 2010; Mahlstedt et al., 2010). The endocyclic alkene of
H2HPPen spontaneously isomerizes to the exocyclic alkene of
H2HPPex (3-(4-hydroxycyclohex-2-enylidene)-2-oxopropanoic
acid). To test whether Plu3043 catalyzes an identical reaction
as its characterized homologs BacA, AerD, and SalX, we turned
to NMR. The 1H-NMR spectrum of the Plu3043-catalyzed reac-
tion product was collected and was identical to that of the previ-
ously characterized H2HPPex (Table S2 and Figure S4) (Mahl-
stedt and Walsh, 2010). This verifies that Plu3043 does indeed
catalyze the reaction characteristic of the PDX enzyme family.
Plu3043 Transaminates H2HPPen to H2Tyr
PDXs convert prephenate to two possible scaffolds that can be
transformed to unique nonproteinogenic amino acids. The first is
the direct product of the reaction, H2HPPen (Figure 1B).
However, this product is unstable and nonenzymatically isomer-
izes to the compound H2HPPex. Our past work has indicated
that H2HPPex is on the pathway to the amino acids anticapsin
(producer, Bacillus subtilis), choi (Planktothrix agardhii), H4Tyr
(Bacillus subtilis), and H4Phe (Salinispora tropica; Figure 1C). In
the case of anticapsin and choi biosynthesis, the biosynthetic
gene clusters encode an enzyme (BacB and AerE, respectively)
that can accelerate the H2HPPen to H2HPPex isomerization.
However, with H4Phe biosynthesis we have not identified an
isomerase that can perform a similar reaction, and so at the
present, we must work with the assumption that this conversion
occurs nonenzymatically in vivo. In considering the biosynthesis
of H2Phe, we propose a novel use of the H2HPPen scaffold that
contrasts with the previously studied pathways. Ultimately, in
forming H2Phe, the ring olefins need to be brought out of conju-
gation. We suspected that this could be accomplished more
readily on the less stable, less extensively conjugated H2HPPen1106 Chemistry & Biology 18, 1102–1112, September 23, 2011 ª201as opposed to the fully conjugated H2HPPex. We hypothesized
that the nonenzymatic isomerization could be prevented by
transamination of the a-keto acid H2HPPen to the amino acid
L-H2Tyr ((S)-2-amino-3-((R)-4-hydroxycyclohexa-1,5-dienyl)
propanoic acid). This reaction replaces the pyruvyl ketone with
a primary amine and removes the driving force for isomerization
because theC=Op electronswould no longer be present. Given
the homology to aminotransferases, we tested the enzyme
Plu3042 for activity with the H2HPPen product.
This hypothesis was first assessed by UV/Vis spectroscopy.
The H2HPPex product has a characteristic chromophore at
295 nm. Reactions containing prephenate and Plu3043 would
ultimately display this 295 nm chromophore if left long enough
for the nonenzymatic H2HPPen to H2HPPex transformation to
occur. However, reactions containing Plu3042 and an accepted
amino acid cosubstrate in addition to Plu3043 and prephenate
would produce the less colorful H2Tyr, and H2HPPex would
not be formed. To determine the best amino acid cosubstrate
for Plu3042, all 20 proteinogenic amino acids were tested in
reactions, and the products were analyzed by scanning from
220 to 600 nm (Figure 5B; Table S4). It was found that inclusion
of L-Gln best precluded formation of the 295 nm chromophore,
supporting our hypothesis and implicating L-Gln as the optimal
amino donor. Other amino acids, such as L-Leu, displayed
some activity with Plu3042, though to a lesser extent than
L-Gln. This is not unexpected given general substrate promis-
cuity of transaminases (Taylor et al., 1998).
Further structural confirmation of the Plu3043-Plu3042 pro-
duct came from NMR experiments. These reactions contained
both the cosubstrate L-Gln and coproduct 2-oxo-glutaramate,
which complicated analysis of spectra. To mask signal from
these compounds, a poly-deuterated Gln (2,3,3,4,4-D5) was
utilized in the enzyme reactions. 1H, gCOSY, gHSQC, and
gHMBC spectra were collected on the enzymatic product,
which confirmed its assignment as H2Tyr (Table 2 and Figures
5A and 5C; S5A–S5C). Three olefinic protons are observed in
the 1H spectrum: H5 at dH 6.07, H6 at dH 6.02, and H9 at dH
5.78. Coupling between H5 and H6 is observed, as well as
between H6 and the H7 proton a to the alcohol at dH 4.26.
The downfield chemical shift of H7 indicates retention of the
C7-OH group. 2D gCOSY reveals coupling of H7 to a proton
peak at dH 2.48, which is in turn coupled to the olefinic proton
H9. Integration of the
1H-NMR peak at 2.48 indicates two
protons, H8a and H8b, and the gHSQC phase information
verifies that an even number of protons are bound to C8 at dC
31.52. This extensive spin system confirms assignment of the
cyclohexadienyl side chain. The a proton H2 is present at dH
3.77, and is coupled to the H3a and H3b protons at dH 2.56
and 2.70. By gHMBC we observe a spin system between
each of these protons and C1 at dC 174.83, completing the
assignment.
DISCUSSION
The compound H2Phe has been long known both as a syntheti-
cally reduced form of Phe (Snow et al., 1968) and as a natural
product (Scannell et al., 1970; Yamashita et al., 1970; Fick-
enscher et al., 1971; Onishi et al., 1982; Feistner, 1988), though
little has been known about its biosynthesis until this work.1 Elsevier Ltd All rights reserved
Figure 4. Isotopic-Labeling Studies on 2,5-Dihydrostilbene Biosynthesis
(A) Birch reduction of 13C6-L-Phe to
13C6-L-H2Phe, which was used to label 2,5-dihydrostilbene in the P. luminescens hexA mutant.
(B) Representative ultraviolet absorption trace from the LC/MS data set. The asterisk (*) marks the 2,5-dihydrostilbene peak in the organic extract analysis.
The major aromatic stilbene is also indicated, which primarily utilizes Phe as a metabolic precursor, but oxidative aromatization of the 1,4-cyclohexadienyl ring in
2,5-dihydrostilbene also leads to the aromatic stilbene.
(C) Increasing quantities of exogenous 13C6-L-H2Phe led to increased 2,5-dihydrostilbene production in the hexA mutant, as judged by integrating the LC peak
(l = 210 nm; error bars represent SD).
(D) Isotopic enrichment of 2,5-dihydrostilbene. TheMS ion current peaks were integrated for the 12C- (ion current window, 254.7–255.7) and 13C6-labeled (260.7–
261.7) products (error bars represent SD).
See also Figure S2.
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et al., 1978), we hypothesized the involvement of a member of
the newly characterized PDX class of enzymes in catalyzing
the first transformation in the H2Phe biosynthetic pathway.
A BLAST search revealed a gene encoding a likely PDX inChemistry & Biology 18, 1102–111the known H2Phe producer E. amylovora, as well as in
P. luminescens, an organism not known to produce H2Phe.
Moreover, the PDX candidates were identified in an eight-gene
cluster in both bacterial genomes. This eight-gene cluster is
also found in Pseudomonas syringae pv syringae FF5. Although2, September 23, 2011 ª2011 Elsevier Ltd All rights reserved 1107
Figure 5. Transamination of H2HPPen Averts Spontaneous Exocyclic Double-Bond Isomerization to Yield L-H2Tyr Most Plausibly on Path
to L-H2Phe
(A) Dual-enzyme reaction to produce H2Tyr. See also Figure S4 and Table S2.
(B) UV/Vis test of Plu3042 activity. Prephenate, Plu3042, Plu3043, and a variety of amino acids were incubated overnight at room temperature. Plu3043
decarboxylates prephenate to H2HPPen. When the added amino acid serves as a cosubstrate for the PLP-dependent transamination of H2HPPen, nonenzymatic
isomerization to H2HPPex is prevented, precluding observance of the H2HPPex peak at 295 nm (as in the case with Gln, and to a lesser extent with Leu and Ile).
See also Table S4.
(C) 1H-NMR of H2Tyr from reaction in (A). H2HPPex contaminant peaks are labeled in red; H2Tyr peaks in green.
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another Pseudomonas has been shown to produce the com-
pound (Onishi et al., 1982). In this work, we have established
H2Phe as a product of P. luminescens and used genetic dele-
tions of genes plu3042, plu3043, plu3044, and plu3045 to verify
that this cluster is involved in production of H2Phe.
Using isotopic-labeling studies, we showed that H2Phe is
incorporated into the reduced stilbene 2,5-dihydrostilbene.
The biosynthesis of the aromatic stilbene derived from Phe
was previously described (Joyce et al., 2008). In part, a Phe
ammonia lyase converts Phe to cinnamate, which accumulates
in the culture medium (Paik et al., 2005; Chalabaev et al.,
2008). During expression of the stilbene pathway, cinnamate
is utilized as a precursor of the downstream type II polyketide
synthase proteins involved in bacterial stilbene biosynthesis.
Phe ammonia lyases are known to accept H2Phe to produce
the corresponding 2,5-dihydrocinnamate (Hanson et al.,
1979). As expected, we observed a low-abundance ion pro-
duct in the cleared spent culture medium consistent with
2,5-dihydrocinnamate. It is likely that H2Phe is converted to1108 Chemistry & Biology 18, 1102–1112, September 23, 2011 ª2012,5-dihydrostilbene via promiscuity in the stilbene biosynthetic
machinery.
In this study, in vitro biochemical investigations have found
that formation of H2Phe likely arises from the H2HPPen product
of PDX Plu3043. This pathway contrasts with the prephenate-
derived secondary metabolic pathways previously investigated,
which use the stable H2HPPex in formation of nonproteinogenic
amino acids (Mahlstedt andWalsh, 2010; Mahlstedt et al., 2010).
The PLP-dependent transaminase Plu3042 then converts
H2HPPen to the amino acid L-H2Tyr, a compound that no
longer isomerizes to an exocyclic diene-containing counterpart
(Figure 5).
Although we have shown that prephenate can be converted
to H2Tyr, the enzymatic reactions that would be required to
convert this to H2Phe remain to be elucidated. This transforma-
tion would require a two-electron reduction and a dehydration.
Through our genetic work we have identified an additional
gene product, Plu3044, that is critical to H2Phe production.
Intriguingly, this protein displays only weak homology to other
characterized enzymes including AhpD (Table S1), a disulfide1 Elsevier Ltd All rights reserved
Table 2. 1H and 13C Data for H2Tyr in D2O
13Ca ppm 1H ppm, mult (Hz) gCOSY gHMBC
1 174.83
2 53.83 3.77, ddd (8.2, 4.7, 1) 3a, 3b 1, 3, 9, 4/5/6c
3a 36.57 2.7, dd (14.7, 4.7) 2, 3b 1, 2, 9, 4/5/6c
3b 2.56, dd (14.7, 8.2) 2, 3a 1, 2, 9, 4/5/6c
4 127.5b
5 127.6 6.07, dd (9.7, 1) 6, 9 3, 7, 9, 4/5/6c
6 127.38 6.02, dd (9.7, 5) 5, 7 7, 8, 4/5/6c
7 61.87 4.26, dt (7, 4.8) 6, 8a/b 8, 9, 4/5/6c
8a 31.52 2.48, m 7, 9 2, 7, 9, 4/5/6c
8b 2.48, m 7, 9 2, 7, 9, 4/5/6c
9 125.17 5.78, br t (4) 5, 8a/b 3, 7, 8
See also Figure S5. mult, multiplicity.
aCarbon shifts assigned by HSQC and HMBC.
bAn exact 13C chemical shift for C4 could not be assigned, though HMBC
analysis suggests that it is in the range of 127–128 ppm.
cCarbons 4/5/6 are indistinguishable by HMBC due to similar chemical
shifts.
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2003) and MA3736, a disulfide reductase that contains an
iron-sulfur cluster (Lessner and Ferry, 2007). Each of these
enzymes contains a crucial CXXC motif. However, Plu3044
only contains one of these critical Cys residues. In fact, there is
only one additional Cys in the entire 180 amino acid Plu3044
sequence, located significantly C terminal to the first. Thismakes
it unlikely that this protein binds a [FeS] cluster and suggests
that it may have a function distinct from its disulfide reductase
homologs.
We have purified this protein to near homogeneity through
heterologous expression in E. coli at high yield of soluble protein
(25mg/l), suggesting that the protein is properly folded. The puri-
fied protein displays no absorbance characteristic of an iron-sul-
fur cluster or any other readily identifiable cofactor. Unfortu-
nately, to date, we have not detected any conversion of H2Tyr
to H2Phe in the presence of Plu3044 or a codon-optimized
E. amylovora homolog Eamy2206, despite testing with a selec-
tion of protein constructs and reaction conditions (detailed in
Supplemental Experimental Procedures). It is not yet clear how
H2Tyr is converted by net replacement of the C4-OH by -H on
the way to H2Phe. Completion of the pathway will require future
work, likely investigating the other genes in the eight-gene
cluster for unexpected biosynthetic activity.
SIGNIFICANCE
Because microbial genome sequence information is gener-
ated at an exponential rate, we continue to observe
a growing biosynthetic potential for the construction of
structurally diverse small molecules, some of which would
be expected to regulate complex symbiotic interactions or
have therapeutic applications. Most of these biosynthetic
pathways observed in microbial genome sequences are
‘‘orphaned,’’ and they either encode completely new molec-
ular scaffolds yet to be discovered or previously discovered
molecules in which we know very little about their biosyn-Chemistry & Biology 18, 1102–111thesis (Davies, 2011; Winter et al., 2011). The connection of
the previously orphaned eight-gene cluster located in the
genomes of the plant pathogen E. amylovora and the insect
pathogen P. luminescens to the synthesis of H2Phe illus-
trates how primary metabolites such as prephenate can
be routed in diverse ways to antibiotic synthesis. In this
case, the known broad activities of L-H2Phe against other
microbes, plants, and animals would contribute to a
successful pathogenesis. More broadly, the endocyclic or
exocyclic H2HPP intermediates can be selectively pro-
cessed to produce a range of products, such as H2Phe,
H4Phe, H2Tyr, H4Tyr, choi, and anticapsin. Given the struc-
tural diversity arising from PDX (prephenate decarboxylase)
homologs and their involvement in antibiotic synthesis,
PDX sequences could be utilized as a powerful genome-
mining tool for the identification of novel nonproteinogenic
amino acids or elaborated natural products. Indeed, in
P. luminescens, H2Phe is further advanced to a dihydrostil-
bene derivative. Aromatization of the cyclohexadienyl side
chain when subjected to the insect’s oxidative defenses
would lead to a product known to serve as an antibiotic
and a developmental modulator of its animal hosts.
EXPERIMENTAL PROCEDURES
Materials
E. coli TOP10 and BL21(DE3) competent cells were purchased from Invitro-
gen. Plasmid pET-28b was purchased from Novagen. DNA oligomers were
ordered from Integrated DNA Technologies. PfuTurbo DNA polymerase was
acquired from Stratagene. Restriction enzymes, Phusion DNA polymerase,
and Taq DNA Ligase were purchased from New England BioLabs. T5 exonu-
clease was acquired from Epicentre Biotechnologies. Plasmid and oligonucle-
otide purification was performed with kits from QIAGEN. The Molecular
Biology Core Facilities at the Dana-Farber Cancer Institute (Boston) performed
DNA sequencing. Nickel-nitrilotriacetic acid agarose (Ni-NTA) resin was
purchased from QIAGEN. Protein concentration was determined using a Coo-
massie Plus Kit from Pierce with BSA as a standard. Bio-Rad Mini-Protean
TGX gels were used for SDS-PAGE. Proteolytic digestion and protein identifi-
cation using an ABI4800 MALDI/TOF-TOF were performed at the Dana-
Farber/Harvard Cancer Center Cancer Proteomics Core facility.
Chemicals were purchased from Sigma-Aldrich, except (2,3,3,4,4-D5)-L-
glutamine, which was obtained from Cambridge Isotope Laboratories.
Enzyme reactions were quenched by filtration using 0.5 ml Millipore Amicon
Ultra 10 kDa MWCO centrifugal filter devices. NMR solvents were obtained
from Cambridge Isotope Laboratories. The 100 3 2.1 mm 5 mm Hypercarb
column used for analytical HPLC was acquired from Thermo Scientific.
Instrumentation
UV/Vis spectroscopic analysis was performed using a Varian Cary 50 Bio
UV-Visible Spectrophotometer. 1H- and 2D-NMR spectra were recorded on
a Varian Inova 600 MHz spectrometer at the Harvard Medical School East
Quad facility. High-resolution LC/MS data were collected on an Agilent 6520
Accurate-Mass Q-TOF Mass Spectrometer fitted with an electrospray ioniza-
tion (ESI) source. A 503 2.1 mm 5 mmHypercarb column from Thermo Scien-
tific was used for high-resolution-LC/MS. Low-resolution LC/MS data were
collected on an Agilent 6130 single quadrupole with an ESI source. Analytical
reverse-phase HPLC was performed on a Beckman Coulter System Gold
instrument (126 solvent module, 168 detector) or on an Agilent 1100 system.
Preparation of Knockout Constructs
Deletion constructs for the generation of scar-less mutants were individ-
ually prepared for genes plu3042, plu3043, plu3044, and plu3045 in
P. luminescens TT01. The gDNA from P. luminescens TT01 was isolated as
previously described (Syn and Swarup, 2000), and the direct upstream region2, September 23, 2011 ª2011 Elsevier Ltd All rights reserved 1109
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and Plu304(2, 3, 4, or 5)-A3 (Table S3). The direct downstream region of each
gene was amplified using primer pairs Plu304(2, 3, 4, or 5)-B5 and Plu304(2, 3,
4, or 5)-B3. These upstream and downstream PCR products for each gene
served as templates in a final overlap-extension PCR reaction, using primer
pairs Plu304(2, 3, 4, or 5)-A5 and Plu304(2, 3, 4, or 5)-B3. The resulting fused
exchange sequences cleanly excised the coding sequences of interest. The
exchange sequence PCR product was digested with SacI and inserted into
the suicide plasmid pDS132 (Philippe et al., 2004), which contains a chloram-
phenicol-resistance marker, generating pDD3042, pDD3043, pDD3044, and
pDD3045. Cloning was carried out in the E. coli DH5a l-pir strain (WM3618
l-pir) to propagate the suicide plasmid. The deletion constructs were verified
by restriction analysis and sequencing.
Construction of Scar-less Deletion Mutants
Scar-less deletion mutants of genes plu3042, plu3043, plu3044, and plu3045
were constructed using similar methods as previously described (Crawford
et al., 2010). The deletion constructs, pDD3042, pDD3043, pDD3044, and
pDD3045, were transformed by heat shock into the diaminopimelic acid
auxotroph donor E. coli strain WM6026 l-pir (Blodgett et al., 2007), and trans-
formants were selected on Luria Bertani (LB) agar plates containing 25 mg/ml
chloramphenicol. P. luminescens TT01 wild-type was grown on LB plates
without selection. The donor E. coli strains and the recipient P. luminescens
TT01 were then cultivated at 37C and 30C, respectively, in suspension
with or without appropriate drug selection. The LB suspension cultures were
timed so that they would simultaneously reach OD600 = 0.5–0.6. The mid-
exponential phase cultures were mixed at a 2:8 and 1:1 (donor:recipient) ratio
(1 ml final), diluted to 5 ml with fresh LB medium, and filtered through a 0.2 mM
sterile filter. The filter was removed, placed on an LB agar plate supplemented
with 0.3 mM diaminopimelic acid, and grown overnight at 30C. The mating
mixture was resuspended in fresh LB and plated on LB agar plates supple-
mented with 25 mg/ml chloramphenicol but lacking supplemental diaminopi-
melic acid. Single P. luminescens colonies growing on the chloramphenicol
selection plates were carefully picked and restreaked on LB sucrose (5%)
plates lacking drug for SacB counter-selection. Successful scarless deletion
mutants from the allelic-exchange process were screened by colony PCR,
using primer pairs Plu3042-5genome and Plu3045-3genome (Table S3). Dele-
tion mutants were restreaked three times on LB sucrose (5%) plates, and the
single colonies were validated by colony PCR a second time to ensure no
wild-type contamination. The final PCR products were cloned into pCR2.1
TOPO (Invitrogen) and end sequence verified.
Metabolite Analysis of Mutants
P. luminescens TT01 D3042, D3043, D3044, D3045, and the wild-type parent
strains were individually streaked on LB agar plates and grown for 2 days at
30C. Single colonies were inoculated into 5 ml of LB and grown overnight
at 30C and 250 rpm. The overnight culture (500 ml) was used to inoculate
50 ml of M9minimal medium, except the glucose carbon source was replaced
with 0.4% casamino acids and 0.576% L-proline to enhance metabolite
production (Crawford et al., 2010). The culture was incubated for 48 hr at
30C and 250 rpm. At 48 hr, the cells were removed by centrifugation and
then the cleared medium was filtered through a 0.2 mm nylon membrane.
The cell-free aqueous solutions containing the secreted small molecules
were analyzed directly by HPLC/MS (Agilent 6130) in positive and negative
ion modes. Separation was carried out over a Hypercarb HPLC column
(1003 4.6 mm, 5 mMparticle size, Thermo Scientific) with an acetonitrile:water
gradient containing 0.1% formic acid at 0.7 ml/min: 0–2 min, 5% MeCN; 2–
25 min, 5%–100% MeCN (Figure 3B; Figure S2B).
Isolation of H2Phe
The M+H = 168 ion eluting at 8.6 min in the wild-type and D3045
P. luminescens cultures was isolated for NMR characterization.
P. luminescens (600 ml) was grown as described in the ‘‘Metabolite Analysis
of Mutants’’ section. The filtered spent medium was lyophilized, and the
powder was extracted with 200 ml of methanol and filtered to remove salts
and highly polar metabolites. The methanol extract was dried, redissolved in
water, and separated over a 2 gC18SepPak column (Waters) using amethanol
gradient (0%, 20%, 40%, and 100% methanol). The compound of interest1110 Chemistry & Biology 18, 1102–1112, September 23, 2011 ª201eluted in both the 0% and 20% methanol washes, but the 20% fraction was
considerably more pure and enriched primarily in Phe and H2Phe. A semi-
preparative Luna phenyl-hexyl HPLC column (250 3 10 mm, 5 mM particle
size; Phenomenex) was needed to separate and isolate H2Phe from the
undesired Phe using a 5% acetonitrile isocratic method (23.4 min retention
time, isolation 1) or a 5% methanol isocratic method (40.5 min retention
time, isolation 2) at 2 ml/min.
Structural Characterization of H2Phe
The high-resolution mass of the M+H ion for the purified product was consis-
tent with the molecular formula of protonated H2Phe (C9H14NO2; calculated
168.1025; observed, 168.1026; error 0.6 ppm). NMR characterizations (1H,
gCOSY, HSQCAD, and gHMBC) were performed with a Varian INOVA
600 MHz NMR using deuterated water and a symmetrical NMR microtube
susceptibility matched to the solvent (Shigemi, Inc.).
Determination of Absolute Configuration of L-H2Phe
Theabsolute configurationwasdeterminedbyMarfey’s analysis (Marfey, 1984;
Fujii et al., 1997). A total of 50ml (10mg/ml) ofNa(2,4-dinitro-5-fluoro-phenyl)-L-
alaninamide in acetone was added to 100 ml of L-Phe (1mg/ml), DL-Phe (1mg/
ml), or isolatedH2Phe (subjected to ten rounds of rotary evaporation fromwater
to aromatize a portion of the product) in 1 N NaHCO3. Themixture was reacted
for 15min at 55C in a water bath. The reaction was quenched with 50 ml of 2 N
HCl. The products were dissolved by adding 150 ml of acetonitrile and further
diluted with 150 ml of water (500 ml total). The products (15 ml) were analyzed
by LC/MS (Agilent 6130) using a Kinetex C18 HPLC column (100 3 4.60 mm,
100 A˚, 2.6 mm particle size; Phenomenex) with an acetonitrile:water gradient
containing 0.1% formic acid at 0.5 ml/min: 0–50 min, 20%–70% MeCN; 50–
51 min, 70%–100% MeCN; 51–56 min, 100% MeCN (Figure S1F).
Synthesis of 13C6-Labeled L-H2Phe
The procedure was adapted from a known protocol (Skolaut and Re´tey, 2001).
Under an inert atmosphere of dry N2, a flame-dried 25 ml two-neck round-
bottom flask, fitted with a Dewar condenser and equipped with a magnetic
stir bar, was charged with 13C6-labeled L-Phe (144 mg, 0.842 mmol). The
Dewar condenser was chilled to 78C (dry ice/acetone), and the flask was
also allowed to cool to 78C (dry ice/acetone). Ammonia (10 ml) was
then condensed into the round-bottom flask via the Dewar condenser; the
homogeneous solution was allowed to stir. Ethanol (1 ml) was added. Finely
cut pieces of sodium (excess) were then added through the second neck of
the flask (otherwise sealed with a glass stopper) until a blue color persisted.
After 8 min, the reaction mixture solidified, and so the cooling bath was
removed (mixture melted shortly thereafter). After an additional 15 min, the
mixture was exposed to the atmosphere and allowed to warm to room temper-
ature, permitting the ammonia to evaporate; the ethanol was removed in
vacuo. The remaining white solids were dissolved in minimal water, and the
solution was adjusted to pH 7 by the dropwise addition of 6 M aqueous HCl
(exothermic). Purification by preparative HPLC (19 3 250 mm SunFire C18
OBD 5 mM column, 15 ml/min, 100% H2O [0.1% TFA] for 3 min, then linear
gradient to 95:5 MeCN:H2O [0.1% TFA] over 17 min) afforded the
13C6-labeled
2,5-dihydrophenylalanine (67.5 mg, 0.390 mmol, 46.3% yield) as a colorless
solid. 1H-NMR (600 MHz, D2O): d 5.90–5.48 (3H, m), 3.99 (1H, app ddd, J =
8.4, 3.6, 3.6 Hz), 2.80–2.59 (3H, m), 2.59–2.40 (3H, m); 13C-NMR (100 MHz,
D2O) d 171.9, 128.9–123.7 (4C, m), 53.6, 37.8 (d, JC–C = 41.0 Hz), 27.7–25.6
(2C, m); High Res LCMS [M+H]+ calc: 174.1226, found: 174.1222.
Isotopic Labeling of 2,5-Dihydrostilbene
The P. luminescens hexA insertional inactivant (Kontnik et al., 2010) was
streaked on LB agar plates supplemented with 25 mg/ml chloramphenicol
and grown for 3 days at 30C. The colonies were used to inoculate liquid LB
(5 ml) with 25 mg/ml chloramphenicol. The suspension culture was grown
overnight at 30C and 250 rpm. A total of 100 ml of overnight seed culture
was used to inoculate 5 ml of M9 minimal medium lacking drug selection, in
which the M9 glucose carbon source was substituted with 0.4% casamino
acids and 0.576% L-proline. The M9 suspension cultures were grown at
30C and 250 rpm until OD600 = 0.5. Synthetic
13C6-L-H2Phe (350 mM stock
in water) was added to the cultures at a final concentration of 0, 0.05, 0.075,
0.125, 0.25, 0.5, 0.75, 1, and 2 mM in triplicate (27 cultures total). The cultures1 Elsevier Ltd All rights reserved
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cultures were individually extracted with 5 ml of ethyl acetate, and the liquid
phases were nicely separated by centrifugation. The top 4 ml of ethyl acetate
was transferred to a separate glass vial, dried, and resuspended in 500 ml meth-
anol for LC/MS analysis. The products (25 ml) were analyzed by LC/MS (Agilent
6130) using aKinetexC18HPLCcolumn (10034.60mm, 100 A˚, 2.6mmparticle
size; Phenomenex) with an acetonitrile:water gradient at 0.7 ml/min: 0–2 min,
10%MeCN; 2–25min, 10%–100%MeCN;25–27min, 100%MeCN (Figure4A).
Cloning, Expression, and Purification of Plu3042, Plu3043,
and Plu3044
Genes encoding Plu3042, Plu3043, and Plu3044 were cloned from
P. luminescens genomic DNA using the following primers:
plu3042, 50-AGCAGCGGCCTGGTGCCGCGCGGCAGCCATATGACAAA
CAATATCGTTAGCCCAGTTAAT-30 and 50-ACCCATTTGCTGTCCACCA
GTCATGCTAGCCTAATAAACCGGATTTAACCAATGTGAGAA-30;
plu3043, 50-AGCAGCGGCCTGGTGCCGCGCGGCAGCCATATGGAATG
TGTTTTTTTTAGTTTCTACAAA-30 and 50-ACCCATTTGCTGTCCACCAGT
CATGCTAGCTTATGCGGCTGTAAATACTGACCAAAGCAT-30;
plu3044, 50-AGCAGCGGCCTGGTGCCGCGCGGCAGCCATATGTCTTT
ACTTACGCTACACACCATTACT-30 and 50-ACCCATTTGCTGTCCACCA
GTCATGCTAGCTTAAAGGTCGTCCAGTTTGAATTTATCATC-30.
After PCR purification, the genes were ligated into plasmid pET-28b nicked
at the Nde1 restriction site using the one-step isothermal DNA assembly
protocol previously developed (Gibson et al., 2009). Plasmids were trans-
formed into chemically competent E. coli TOP10, then purified and sequenced
to verify correct gene insertion. Purified plasmid encoding each gene with
a N-terminal His6 tag was transformed into chemically competent BL21(DE3)
cells for protein expression.
Cultures of expression cells in LB Broth supplemented with 50 mg/ml kana-
mycin were grown at 37C until the OD600 reached 0.4. The temperature was
then dropped to 15C. Once cooled, the cells were induced with 120 mM IPTG
and grown overnight. Cells were harvested by centrifugation at 5,000 3 g for
8 min, resuspended in 50 mM potassium phosphate (pH 8), 150 mM sodium
chloride (lysis buffer), then lysed via three passes at 5,000–10,000 psi in an
Avestin EmulsiFlex-C5 high-pressure homogenizer. Cell lysate was clarified
by centrifugation at 35,000 3 g for 35 min at 4C. The supernatant was then
incubated with 1.5 ml Ni-NTA resin, while rocking, at 4C for 2 hr. The resin
was washed once with lysis buffer, and once with lysis buffer supplemented
with 5 mM imidazole. A stepwise gradient of lysis buffer supplemented with
20, 40, 60, and 200 mM imidazole was used to elute protein from the column.
SDS-PAGEwas used to identify fractions containing the desired protein, which
were then combined and dialyzed in lysis buffer to remove imidazole. Protein
was flash frozen and stored at 80C.
Structural Elucidation of Plu3043 Reaction Product
Plu3043 is a predicted PDX with homology to enzymes BacA, AerD, and SalX
that we have previously characterized (Mahlstedt and Walsh, 2010; Mahlstedt
et al., 2010). To verify that Plu3043 produces the same H2HPP product, NMR
spectroscopy was used, and the resulting 1H-NMR spectrum compared to the
previously reported 1H spectra for H2HPPex. Reactions were set up using
previously reported methodology (Mahlstedt et al., 2010). The reaction
product was dissolved in D2O before NMR analysis.
Determination of Amino Acid Cosubstrate for Plu3042
As a predicted PLP-dependent aminotransferase, the enzyme Plu3042
requires an amino acid cosubstrate for activity. To identify the best amino
acid cosubstrate, an UV/Vis spectroscopic assay was utilized. A total of
1 mM prephenate was incubated with 2 mM each of 3 of the 20 standard pro-
teinogenic amino acids (Trp and Tyr were tested individually), 20 mM PLP,
10 mM Plu3042 and 10 mM Plu3043 in 50 mM potassium phosphate (pH 8)
(50 ml total volume) at room temperature overnight. Controls with no amino
acid added or no Plu3043 added were set up at the same time under identical
conditions. Following incubation, 20 ml of each reaction mixture was diluted
with 200 ml water and scanned from 220 to 600 nm. When no amino acid
was included, the reaction mixture displayed absorbance at 295 nm, charac-Chemistry & Biology 18, 1102–111teristic of H2HPPex. The same is true when amino acids that are not capable of
serving as cosubstrates for Plu3042 were included. However, when a correct
amino acid was included, the samples did not absorb at 295 nm. The sample
yielding the least absorbance at 295 nm included Gln, Ile, and Leu. To identify
which of these three amino acids was the optimal cosubstrate, reactions were
set up and analyzed as described above; however, they only contained 2 mM
of one amino acid (Gln, Ile, or Leu). Reactions with no amino acid and with Lys
were used as controls.
Structural Elucidation of Plu3042 Product
NMR structural characterization of the product of the Plu3043-Plu3042 reac-
tion was desired. To produce enough sample for analysis, a 500 ml reaction
including 20 mM prephenate, 40 mM (2,3,3,4,4-D5)-L-glutamine, 30 mM PLP,
20 mM Plu3042, and 20 mM Plu3043 in 50 mM potassium phosphate (pH 8)
was incubated overnight at room temperature. The reaction was quenched
by filtration to remove the enzyme and lyophilized. The solid-reaction product
was dissolved in 700 ml D2O, and
1H, gCOSY, gHSQC, and gHMBC spectra
were collected.SUPPLEMENTAL INFORMATION
Supplemental Information includes four tables, five figures, and Supplemental
Experimental Procedures and can be found with this article online at doi:10.
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